These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 8935302)
1. Ambulatory blood pressure monitoring for evaluation of long-acting beta-blockers in Taiwan. Tseng CD; Tseng YZ; Lo HM; Chiang FT; Hsu KL J Formos Med Assoc; 1996 Apr; 95(4):320-4. PubMed ID: 8935302 [TBL] [Abstract][Full Text] [Related]
2. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study. Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME; Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199 [TBL] [Abstract][Full Text] [Related]
3. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study. Shimada K; Ogihara T; Saruta T; Kuramoto K; Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of combination antihypertensive therapy with low-dose indapamide: assessment by blood pressure self-monitoring at home. Hashimoto J; Hirayama H; Hanasawa T; Watabe D; Asayama K; Metoki H; Kikuya M; Ohkubo T; Totsune K; Imai Y Clin Exp Hypertens; 2005 May; 27(4):331-41. PubMed ID: 15921070 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of two ramipril and hydrochlorothiazide fixed-dose combination formulations in adults with stage 1 or stage 2 arterial hypertension evaluated by using ABPM. Oigman W; Gomes MA; Pereira-Barretto AC; Póvoa R; Kohlmann O; Rocha JC; Nobre F Clin Ther; 2013 May; 35(5):702-10. PubMed ID: 23623755 [TBL] [Abstract][Full Text] [Related]
6. [Antihypertensive effect of valsartan 80 mg and hydrochlorothiazide 12.5 mg evaluated by ambulatory blood pressure monitoring]. Vaïsse B; Ghobrial H; Vaur L; Poncelet P; Asmar R; Herpin D; Mallion JM Arch Mal Coeur Vaiss; 2001 Aug; 94(8):907-12. PubMed ID: 11575229 [TBL] [Abstract][Full Text] [Related]
7. Blood pressure control by the nifedipine GITS-telmisartan combination in patients at high cardiovascular risk: the TALENT study. Mancia G; Parati G; Bilo G; Choi J; Kilama MO; Ruilope LM; J Hypertens; 2011 Mar; 29(3):600-9. PubMed ID: 21252701 [TBL] [Abstract][Full Text] [Related]
8. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring. Lacourcière Y; Neutel JM; Davidai G; Koval S Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of olmesartan/amlodipine/hydrochlorothiazide in patients with hypertension not at goal with mono, dual or triple drug therapy: results of the CHAMPiOn study. Punzi HA Ther Adv Cardiovasc Dis; 2014 Feb; 8(1):12-21. PubMed ID: 24492985 [TBL] [Abstract][Full Text] [Related]
10. Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients. Hermida RC; Ayala DE; Crespo JJ; Mojón A; Chayán L; Fontao MJ; Fernández JR Chronobiol Int; 2013 Mar; 30(1-2):176-91. PubMed ID: 23077974 [TBL] [Abstract][Full Text] [Related]
12. ACE inhibitor-based, directly observed therapy for hypertension in hemodialysis patients. Zheng S; Nath V; Coyne DW Am J Nephrol; 2007; 27(5):522-9. PubMed ID: 17700014 [TBL] [Abstract][Full Text] [Related]
13. Reduction (TELMAR) as assessed by magnetic resonance imaging in patients with mild-to-moderate hypertension--a prospective, randomised, double-blind comparison of telmisartan with metoprolol over a period of six months rationale and study design. Friedrich MG; Dahlöf B; Sechtem U; Unger T; Knecht M; Dietz R; J Renin Angiotensin Aldosterone Syst; 2003 Dec; 4(4):234-43. PubMed ID: 14689371 [TBL] [Abstract][Full Text] [Related]
14. Differential time effect profiles of amlodipine, as compared to valsartan, revealed by ambulatory blood pressure monitoring, self blood pressure measurements and dose omission protocol. Radauceanu A; Boivin JM; Bernaud C; Fay R; Zannad F; Fundam Clin Pharmacol; 2004 Aug; 18(4):483-91. PubMed ID: 15312156 [TBL] [Abstract][Full Text] [Related]
15. Antihypertensive efficacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertension. Mallion JM; Omboni S; Barton J; Van Mieghem W; Narkiewicz K; Panzer PK; Puig JG; Stefanadis C; Zweiker R; Blood Press Suppl; 2011 Apr; 1():3-11. PubMed ID: 21091270 [TBL] [Abstract][Full Text] [Related]
16. Comparison of daily anti-hypertensive effects of amlodipine and nifedipine coat-core using ambulatory blood pressure monitoring - utility of "hypobaric curve" and "hypobaric area". Kuga K; Xu DZ; Ohtsuka M; Aonuma K; Lau AH; Watanabe Y; Ohtsuka K Clin Exp Hypertens; 2011; 33(4):231-9. PubMed ID: 21699449 [TBL] [Abstract][Full Text] [Related]
17. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT). Frishman WH; Hainer JW; Sugg J; Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575 [TBL] [Abstract][Full Text] [Related]
19. Status of home blood pressure measured in morning and evening: evaluation in normotensives and hypertensives in Japanese urban population. Kawabe H; Saito I; Saruta T Hypertens Res; 2005 Jun; 28(6):491-8. PubMed ID: 16231754 [TBL] [Abstract][Full Text] [Related]
20. Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension. Chrysant SG; Marbury TC; Robinson TD J Hum Hypertens; 2003 Jun; 17(6):425-32. PubMed ID: 12764406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]